Target intelligence / Profile preview

KCTD14 antisense RNA 2 (KCTD14-AS2)

Target
KCTD14-AS2
Molecular classification
Long non-coding antisense RNA, non-protein coding RNA
01

Overview

KCTD14 antisense RNA 2 (KCTD14-AS2) is a long non-coding antisense RNA that is complementary to the protein-coding KCTD14 gene. Antisense RNAs typically regulate gene expression at the transcriptional or post-transcriptional level by binding to sense transcripts, potentially modulating their stability or translation. Antisense lncRNAs are widely distributed throughout eukaryotic genomes and can play roles in epigenetic regulation, gene silencing, or fine-tuning cellular functions, but there is currently no specific data linking KCTD14-AS2 to disease or physiological processes. If you require information about the protein-coding gene KCTD14, which is part of the potassium channel tetramerization domain family, that can be provided separately; however, KCTD14-AS2 itself is not currently catalogued as a therapeutic or molecular target.

Other names
KCTD14-AS2
02

Mechanism of action

Not applicable; no drugs target KCTD14-AS2

03

Biological functions

Gene expression regulation (by analogy to other antisense lncRNAs)
04

Disease associations

None directly reported. Antisense RNAs as a class are sometimes involved in cancer, neurodegenerative disease, and epigenetic silencing, but no published disease relevance for KCTD14-AS2 itself.

Beyond the preview

Go deeper on KCTD14 antisense RNA 2 (KCTD14-AS2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on KCTD14 antisense RNA 2 (KCTD14-AS2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call